Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jennifer Tousignant

General Counsel at Viridian Therapeutics, Inc.\DE (VRDN)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $419K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 20SEC VRDNViridian Therapeutics, Inc.\DE Sell 4,212 $24.50 $103K -22.3%
Aug 20SEC VRDNViridian Therapeutics, Inc.\DE Sell 10,000 $24.50 $245K -22.3%
Jan 2SEC VRDNViridian Therapeutics, Inc.\DE Sell 2,272 $31.16 $71K -38.9%